This video reviews novel treatment approaches in the management of higher-risk myelodysplastic syndromes.
Olatoyosi Odenike, MD
Advertisement
Articles by Olatoyosi Odenike, MD
Advertisement
Latest Updated Articles
Novel Treatment Approaches in Higher-Risk Myelodysplastic SyndromesDecember 17th 2017
Advertisement
Advertisement
Trending on CancerNetwork
1
The Case for Frontline Zongertinib in HER2-Mutant NSCLC
2
Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
3
Acting on a HER2 Result and Navigating Access to Therapy
4
FDA Clears TriNav Advance for Expanded Liver Embolization Access
5